isavuconazole + methotrexate
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacokinetics of Isavuconazole
Conditions
Pharmacokinetics of Isavuconazole, Pharmacokinetics of Methotrexate, Pharmacokinetics of 7-hydroxymethotrexate, Healthy Subjects
Trial Timeline
Feb 1, 2013 → Mar 1, 2013
NCT ID
NCT01884636About isavuconazole + methotrexate
isavuconazole + methotrexate is a phase 1 stage product being developed by Astellas Pharma for Pharmacokinetics of Isavuconazole. The current trial status is completed. This product is registered under clinical trial identifier NCT01884636. Target conditions include Pharmacokinetics of Isavuconazole, Pharmacokinetics of Methotrexate, Pharmacokinetics of 7-hydroxymethotrexate.
What happened to similar drugs?
5 of 5 similar drugs in Pharmacokinetics of Isavuconazole were approved
Approved (5) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01884636 | Phase 1 | Completed |
Competing Products
20 competing products in Pharmacokinetics of Isavuconazole